USPTO serial 97476208
MGS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEPHENS, BRIA MICHELLE
- Law office
- TMO LAW OFFICE 122
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MGS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dana Dickson
408 John Carlyle StAlexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use | ACTIVE | — |
| 005 | Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use | ACTIVE | — |
| 009 | Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use | ACTIVE | — |
| 010 | Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use | ACTIVE | — |
| 042 | Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use | ACTIVE | — |
| 044 | Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Medical diagnostic services, medical diagnostic testing and reporting services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dimension Genomics Inc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MGS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 5, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 5, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 16, 2025 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jan 16, 2025 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Jan 16, 2025 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Apr 11, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 11, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 11, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 9, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 9, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 9, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 10, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 10, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 10, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 3, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2022 | NWAP | NEW APPLICATION ENTERED | — |